Chemical Change Analysis
Coriolis Pharma offers industry-leading chemical change analytics services to ensure the quality, stability and efficacy of your biopharmaceutical compounds. Utilizing our scientific expertise and state-of-the-art technologies, we comprehensively characterize chemical changes that support your formulation development, stability studies and regulatory compliance requirements.
Assessing the Chemical Integrity of Your Biopharmaceutical Compound
Our expert team provides in-depth characterization of chemical changes throughout the biopharmaceutical development process.
Our expert scientists analyze various aspects of biopharmaceutical compounds, including:
- Deamidation
- Hydrolysis
- Oxidation
- Photodegradation
- Disulfide scrambling
- Charge variants
We take samples under accelerated stress conditions and during long-term storage to assess the criticality of different degradation pathways and enable data-driven development of robust and stable drug product formulations.
Our chemical change analysis services are performed under R&D and GMP conditions in dedicated labs with complete quality oversight. These services can be applied to viruses, cells and viral vectors, and fall under biosafety level 2.
Chemical Change Testing Methods
We can select the most suitable approach for your analytical challenge, whether following a standardized in-house workflow or a custom-tailored solution.
Analytical Method Development, Qualification and Validation
For common sample types, we can often apply standardized methods with little setup effort. However, when needed, our experienced analytical experts create or optimize custom methods tailored to your active pharmaceutical ingredient, product type and development phase.
Your Drug Product
Coriolis Pharma’s deep expertise across many biologic modalities, combined with input from world-leading external advisors, offers the knowledge and experience needed to solve even the most complex formulation and drug development challenges.
Your Phase
Our expert team has the expertise and experience to guide your biopharmaceutical development program from preclinical and early-phase development to the market.
Chemical Change Analysis Resources
Publications
April 12, 2024
Publications
April 1, 2024